Last updated on August 2019

A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)

Brief description of study

For participants enrolled prior to Version 6 of the protocol: This is a Phase II multi-center, randomized, double-blind, 24-week, 3-arm, parallel group, placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics of balovaptan in children and adolescents aged 5-17 years with ASD who are high functioning (intelligence quotient [IQ] greater than or equal to [>=] 70).

For participants enrolled according to Version 6 of the protocol: This is a Phase II multi-center, randomized, double-blind, 24-week, parallel group, placebo-controlled, 2-arm study with participants assigned either to a 10 milligram (mg) or equivalent dose of balovaptan, or placebo. All other study parameters remain as stated above.

All participants that complete the 24-week treatment period will be eligible to participate in an optional 52-week open-label extension (OLE) during which they will receive balovaptan treatment.

Clinical Study Identifier: NCT02901431

Find a site near you

Start Over

PCSD Feighner Research

San Diego, CA United States
  Connect »

DBA IMMUNOe Int'l Res Center

Centennial, CO United States
  Connect »

Sarkis Clinical Trials

Gainesville, FL United States
  Connect »

University of South Florida

Saint Petersburg, FL United States
  Connect »

UMASS Medical School

Worcester, MA United States
  Connect »

Richmond Behavioral Associates

Staten Island, NY United States
  Connect »

University Hospitals

Cleveland, OH United States
  Connect »

Ohio State University

Columbus, OH United States
  Connect »

Cutting Edge Research Group

Oklahoma City, OK United States
  Connect »

Relaro Medical Trials

Dallas, TX United States
  Connect »

Road Runner Research

San Antonio, TX United States
  Connect »

Zain Research LLC

Richland, WA United States
  Connect »

Boston Childrens Hospital

Boston, MA United States
  Connect »

Segal trials

North Miami, FL United States
  Connect »

Capstone Clinical Research

Libertyville, IL United States
  Connect »

St. Charles Psychiatric Associates

Saint Charles, MO United States
  Connect »

University of Rochester

Rochester, NY United States
  Connect »

NRC Research Institute

Orange, CA United States
  Connect »

Kennedy Krieger Institute

Baltimore, MD United States
  Connect »

Neuroscientific Insights

Rockville, MD United States
  Connect »

Core Clinical Research

Everett, WA United States
  Connect »